Biological E plans to make 1.5 billion Corbevax jabs in 2021

By 2022, there is a plan to make an mRNA-technology vaccine, for which it has tied up with Canadian firm Providence Therapeutics.The vaccine, named PTX-COVID19-B, is under development in Canada and......

Gradual volume recovery, valuations to support Hindustan Unilever's stock

Hindustan Unilever’s (HUL’s) performance for the quarter ended March 2023 (Q4FY24) was in line with modest consensus expectations. Photograph: Danish Siddiqui/Reuters Net revenue was......

HUL's growth checkout: Navigating the low-volume aisle in Q3 FY24

There is no near-term respite for the country’s largest fast-moving consumer goods maker, Hindustan Unilever (HUL), which is facing multiple challenges on the growth front. Photograph:......

Govt clears GlaxoSmithKline's Rs 6,400-crore FDI proposal

The government on Thursday cleared Rs 6,400-crore (Rs 64-billion) FDI proposal of global healthcare company GlaxoSmithKline to acquire additional 24.33 per cent stake in its India arm. The Cabinet......

FIPB clears GlaxoSmithKline's Rs 6,400-crore FDI proposal

FIPB on Monday cleared Rs 6,400-crore (Rs 64-billion) foreign direct investment proposal of GlaxoSmithKline to acquire additional 24.33 per cent stake in its India arm. "The proposal of......